BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29715101)

  • 21. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
    Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
    Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells.
    Chu YD; Yeh CT
    Cells; 2020 Jul; 9(7):. PubMed ID: 32698392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma.
    Ji Y; Li B; Zhu Z; Guo X; He W; Fan Z; Zhang W
    Biomed Pharmacother; 2015 Feb; 69():409-15. PubMed ID: 25661390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.
    Xing M; Usadel H; Cohen Y; Tokumaru Y; Guo Z; Westra WB; Tong BC; Tallini G; Udelsman R; Califano JA; Ladenson PW; Sidransky D
    Cancer Res; 2003 May; 63(9):2316-21. PubMed ID: 12727856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
    Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
    Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism.
    Alberti L; Proverbio MC; Costagliola S; Romoli R; Boldrighini B; Vigone MC; Weber G; Chiumello G; Beck-Peccoz P; Persani L
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2549-55. PubMed ID: 12050212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new silent germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation.
    Gozu HI; Mueller S; Bircan R; Krohn K; Ekinci G; Yavuzer D; Sargin H; Sargin M; Ones T; Gezen C; Orbay E; Cirakoglu B; Paschke R
    Thyroid; 2008 May; 18(5):499-508. PubMed ID: 18466076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.
    Yamamoto Y; Sakamoto M; Fujii G; Tsuiji H; Kenetaka K; Asaka M; Hirohashi S
    Hepatology; 2003 Mar; 37(3):528-33. PubMed ID: 12601349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
    Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
    Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single strand DNA-binding proteins and thyroid transcription factor-1 conjointly regulate thyrotropin receptor gene expression.
    Shimura H; Shimura Y; Ohmori M; Ikuyama S; Kohn LD
    Mol Endocrinol; 1995 May; 9(5):527-39. PubMed ID: 7565801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma.
    Fu B; Meng W; Zeng X; Zhao H; Liu W; Zhang T
    Biomed Res Int; 2017; 2017():4698167. PubMed ID: 28536696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival.
    Li T; Yin J; Yuan L; Wang S; Yang L; Du X; Lu J
    Oncol Rep; 2014 Apr; 31(4):1699-706. PubMed ID: 24549282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.